Reveal comprehensive health insights and your risk of lifestyle-related diseases with My Nightingale blood test.
Start building your lifelong health.
My Nightingale blood test measures 250 biomarkers, including results that are not measured in traditional blood tests. The test then analyzes the biomarkers using a proprietary algorithm to evaluate future disease risks not covered by standard health check-ups or physical examinations.Features of My Nightingale
Nightingale Health's internationally recognised technology utilises NMR (Nuclear Magnetic Resonance) and proprietary software to analyse a comprehensive list of biomarkers from blood. The measurement accuracy is at a level that can be used in clinical practice in Europe (CE certified). The technology indicates the risk of developing cardiovascular disease and type 2 diabetes within 10 years. Nightingale’s proprietary algorithms are validated for Japanese people.Find out more
Comprehensive quantitative analysis of
Analysis by proprietary algorithms
validated for Japanese people
A unique summary score that
reveals the risk of developing
After blood collection blood samples are dispensed to cryopreservation tubes,
collected from the medical facility and analyzed in Nightingale Health Japan’s laboratory.
The results report will be typically delivered within 1 to 2 weeks after blood collection.
Fasting for at least 10 hours is required before blood collection. Please use a special blood collection tube (vacuum blood collection tube for serum with separator by Terumo Corporation).
Centrifugation should be performed within one hour after blood collection and the tubes should be dispensed for cryopreservation. The centrifugation conditions should be organised according to the conditions recommended by the blood collection tube manufacturer or general guidelines.
After aliquoting, please store the samples in freezing conditions. A representative from the diagnostic company will come to collect the samples.
The analysis will be conducted at Nightingale Health Japan's laboratory in Tokyo.
A representative of the diagnostic company will typically deliver the results report within 1 to 2 weeks after blood collection.
Nightingale has developed a technology to quantitatively analyze 250 biomarkers from a single blood sample, using NMR (Nuclear Magnetic Resonance) spectroscopy and a proprietary software. In Europe, the technology is a CE-marked IVD device.
Nightingale’s technology is widely used for research purposes. More than 300 scientific publications have been published reporting the associations between Nightingale’s blood test results and various diseases.
My Nightingale's proprietary algorithms are based on large representative population datasets including NMR blood test results and disease history. The algorithm predicts the risk of developing cardiovascular disease and type 2 diabetes within 10 years.